NCT03069625

Brief Summary

Cystic fibrosis (CF) is a chronic hereditary respiratory disease. Exercise testing is part of CF patients regular assessment. Cardio-Pulmonary Exercise Testing (CPET) is currently considered as the gold standard to assess physical capacities. However, simple field tests are emerging. These tests are easier to perform especially in a population of CF children and adolescents. The 1minute Sit-To-Stand test have recently been evaluated in CF adults. This test correlates with maximal oxygen consumption during CPET. The investigators hypothesized that this test also correlates with 6-Minute Walking distance (during a 6-min Walk Test), quadriceps strength, respiratory muscles strength and health-related quality of life.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
36

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Aug 2017

Typical duration for not_applicable

Geographic Reach
1 country

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 16, 2017

Completed
15 days until next milestone

First Posted

Study publicly available on registry

March 3, 2017

Completed
6 months until next milestone

Study Start

First participant enrolled

August 31, 2017

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 24, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 24, 2019

Completed
Last Updated

September 3, 2019

Status Verified

May 1, 2019

Enrollment Period

1.9 years

First QC Date

February 16, 2017

Last Update Submit

August 30, 2019

Conditions

Keywords

Cystic FibrosisExercise TestingMuscular strengthPediatricsQuality of life

Outcome Measures

Primary Outcomes (1)

  • Correlation between number of repetitions (STS Test) and 6-Minute Walking Distance

    Comparison between the results of these two submaximal exercise tests

    This outcome will be measured after both tests realization up to 15 minutes.

Secondary Outcomes (11)

  • Correlation between number of repetitions (STS test) and Maximal Inspiratory Pressure (MIP)

    MIP will be measured after inclusion in the hour before field tests realization.

  • Correlation between number of repetitions (STS test) and Maximal Expiratory Pressure (MEP)

    MEP will be measured after inclusion in the hour before field tests realization.

  • Correlation between number of repetitions (STS Test) and health-related quality of life

    HRQoL testing will be carried out after inclusion in the hour before field tests realization.

  • Correlation between number of repetitions (STS Test) and quadriceps strength.

    Quadriceps strength will be assessed after inclusion in the hour before field tests realization.

  • Correlation between number of repetitions (STS Test) and forced vital capacity (FVC)

    Spirometric test will be carried out before field tests realization.

  • +6 more secondary outcomes

Study Arms (2)

Sit-to-stand test

EXPERIMENTAL

Children and adolescents will perform 2 STS tests. First one is used to eliminate learning effect. Number of repetitions will be noted at the end of the second test.

Behavioral: Sit-to-stand test

6-Minute Walk Test

ACTIVE COMPARATOR

Children and adolescents will perform 2 6MWT tests. First one is used to eliminate learning effect. Number of repetitions will be noted at the end of the second test.

Behavioral: 6-Minute Walk Test

Interventions

CF young patients will perform 2 STS tests. Number of repetitions, cardio-respiratory response and physiological adaptations during the second test will be monitored.

Sit-to-stand test

CF young patients will perform 2 6MWT tests. Number of repetitions, cardio-respiratory response and physiological adaptations during the second test will be monitored.

6-Minute Walk Test

Eligibility Criteria

Age6 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Cystic Fibrosis

You may not qualify if:

  • Cardiovascular, neurological or musculoskeletal contra-indications to exercise testing
  • Other respiratory disease (kyphoscoliosis, asthma ...)
  • Exacerbation
  • Unability to carry out field tests

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Hôpital Côte de Nacre

Caen, France

Location

Le Havre Hospital

Le Havre, 76290, France

Location

CHU de Rouen

Rouen, 76000, France

Location

Related Publications (4)

  • Radtke T, Puhan MA, Hebestreit H, Kriemler S. The 1-min sit-to-stand test--A simple functional capacity test in cystic fibrosis? J Cyst Fibros. 2016 Mar;15(2):223-6. doi: 10.1016/j.jcf.2015.08.006. Epub 2015 Sep 9.

    PMID: 26363563BACKGROUND
  • Ozalevli S, Ozden A, Itil O, Akkoclu A. Comparison of the Sit-to-Stand Test with 6 min walk test in patients with chronic obstructive pulmonary disease. Respir Med. 2007 Feb;101(2):286-93. doi: 10.1016/j.rmed.2006.05.007. Epub 2006 Jun 27.

    PMID: 16806873BACKGROUND
  • Hussey J, Gormley J, Leen G, Greally P. Peripheral muscle strength in young males with cystic fibrosis. J Cyst Fibros. 2002 Sep;1(3):116-21. doi: 10.1016/s1569-1993(02)00074-7.

    PMID: 15463817BACKGROUND
  • Combret Y, Boujibar F, Gennari C, Medrinal C, Sicinski S, Bonnevie T, Gravier FE, Laurans M, Marguet C, Le Roux P, Lamia B, Prieur G, Reychler G. Measurement properties of the one-minute sit-to-stand test in children and adolescents with cystic fibrosis: A multicenter randomized cross-over trial. PLoS One. 2021 Feb 12;16(2):e0246781. doi: 10.1371/journal.pone.0246781. eCollection 2021.

MeSH Terms

Conditions

Cystic Fibrosis

Condition Hierarchy (Ancestors)

Pancreatic DiseasesDigestive System DiseasesLung DiseasesRespiratory Tract DiseasesGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesInfant, Newborn, Diseases

Study Officials

  • Pascal Le Roux, MD

    Groupe Hospitalier du Havre

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SCREENING
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 16, 2017

First Posted

March 3, 2017

Study Start

August 31, 2017

Primary Completion

July 24, 2019

Study Completion

July 24, 2019

Last Updated

September 3, 2019

Record last verified: 2019-05

Locations